Grifols SA ADR (NASDAQ: GRFS) on Monday, plunged -4.47% from the previous trading day, before settling in for the closing price of $8.73. Within the past 52 weeks, GRFS’s price has moved between $5.30 and $12.15.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 6.28%. The company achieved an average annual earnings per share of 94.21%. With a float of $257.30 million, this company’s outstanding shares have now reached $257.44 million.
Let’s determine the extent of company efficiency that accounts for 23744 employees. In terms of profitability, gross margin is 38.04%, operating margin of 14.21%, and the pretax margin is 3.57%.
Grifols SA ADR (GRFS) Breakdown of a Key Holders of the stock
Observing investor behavior towards Drug Manufacturers – General industry stocks is more important than anything else. The insider ownership of Grifols SA ADR is 0.06%, while institutional ownership is 56.89%.
Grifols SA ADR (GRFS) Recent Fiscal highlights
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported 0.12 earnings per share (EPS) for the period falling under the consensus outlook (set at 0.24) by -0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 94.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 61.25% during the next five years compared to -37.97% drop over the previous five years of trading.
Grifols SA ADR (NASDAQ: GRFS) Trading Performance Indicators
Grifols SA ADR (GRFS) is currently performing well based on its current performance indicators. A quick ratio of 0.80 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.25 and is forecasted to reach 1.01 in one year’s time.
Technical Analysis of Grifols SA ADR (GRFS)
Looking closely at Grifols SA ADR (NASDAQ: GRFS), its last 5-days average volume was 0.53 million, which is a drop from its year-to-date volume of 1.93 million. As of the previous 9 days, the stock’s Stochastic %D was 54.36%. Additionally, its Average True Range was 0.28.
During the past 100 days, Grifols SA ADR’s (GRFS) raw stochastic average was set at 67.46%, which indicates a significant increase from 6.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 24.95% in the past 14 days, which was lower than the 54.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.73, while its 200-day Moving Average is $7.64. However, in the short run, Grifols SA ADR’s stock first resistance to watch stands at $8.50. Second resistance stands at $8.66. The third major resistance level sits at $8.76. If the price goes on to break the first support level at $8.24, it is likely to go to the next support level at $8.14. Now, if the price goes above the second support level, the third support stands at $7.98.
Grifols SA ADR (NASDAQ: GRFS) Key Stats
Market capitalization of the company is 2.15 billion based on 687,560K outstanding shares. Right now, sales total 7,135 M and income totals 64,200 K. The company made 1,958 M in profit during its latest quarter, and 15,980 K in sales during its previous quarter.
